Annexon Inc.

ANNX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.22

-$0.01 (-0.24%)

At close: Sep 21, 2026, 4:00 PM ET

$4.21

-$0.01 (-0.36%)

After-hours: Sep 21, 2026, 7:50 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.24%

(1D)

Rating

Updated: Aug 25, 2026

24.5

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $691.42M

1D Range

4.12 4.29

52W Range

2.54 7.18

Valuation (TTM)

PE -3.64

PB 3.72

EV/EBITDA -2.54

Valuation (NTM)

Forward PE N/A

Forward PEG 0.69

Price Target $10.50

Cash Flow

FCF Yield -27.9%

SBC Adj. FCF Yield -30.3%

SBC Impact -8.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 2.9% | 31.2%

FCF 3Y | 5Y -30.4% | -11.8%

Returns

ROA -82.4%

ROE -106.2%

ROIC -99.9%

Financial Health

Net Cash

$209.24M

Current Ratio 5.53

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Annexon, Inc. is a biopharmaceutical company currently engaged in clinical trials, dedicated to the discovery and advancement of therapies for a variety of autoimmune, neurodegenerative, and ophthalmi...

Sector Healthcare

Industry Biotechnology

Employees 92

IPO Date Jul 23, 2020

Website www.annexonbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$10.50

Upside

+148.82%

Buy (4)

Hold (1)

Sell (0)

Analyst Details ➞